[144] Finance of America Companies Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Finance of America Companies, Inc. (FOA) shows an insider intends to sell 750 common shares through Wells Fargo Clearing Services on the NYSE, with an aggregate market value reported as $16,568 and approximately 11,079,270 shares outstanding. The shares were acquired on 09/29/2021 as employee stock grants and payment for those grants is listed as N/A. The filer also reported three prior sales in the past three months by the same person, each for 750 shares with gross proceeds of $19,688.00, $15,707.26 and $17,333.00 respectively. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- Insider sales pattern: The same individual sold 750 shares in each of the past three months and filed to sell another 750 shares, indicating ongoing disposals.
- Lack of 10b5‑1 plan date: The filing does not disclose a Rule 10b5‑1 plan adoption date, so the sales are not documented here as preplanned in this notice.
Insights
TL;DR: Insider plans to sell 750 shares; recent repeated small sales were reported, indicating routine disposition rather than a one‑time large exit.
The filing documents a planned sale of 750 common shares through a broker with an aggregate market value of $16,568 against roughly 11.08 million shares outstanding, indicating the proposed sale is a small fraction of total equity. The securities were acquired as employee stock grants on 09/29/2021. The same individual reported three prior monthly sales of 750 shares each over the past three months, suggesting a pattern of scheduled or opportunistic sales. This filing provides no operational or financial performance data and includes the required certification regarding non‑public material information.
TL;DR: Filing appears procedurally complete for Rule 144 notice; repeated monthly sales warrant monitoring but show no explicit compliance issues.
The notice contains the key Rule 144 elements: broker name, number of shares, aggregate market value, acquisition date and nature (employee stock grants), and recent sales history. The signer asserts no undisclosed material adverse information and no Rule 10b5‑1 plan date is provided. From a compliance perspective, the form records routine dispositions; absence of a disclosed trading plan date means reliance on other exemptions or standard Rule 144 timing requirements may apply. No allegations or regulatory flags are present in the document text itself.